227 related articles for article (PubMed ID: 15804533)
1. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
Hakimelahi GH; Moosavi-Movahedi AA; Tsay SC; Tsai FY; Wright JD; Dudev T; Hakimelahi S; Lim C
J Med Chem; 2000 Oct; 43(20):3632-40. PubMed ID: 11020277
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Lee CS; Lee JS; Cho JH
Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of a series of beta-lactam-based prodrugs.
Hakimelahi GH; Shia KS; Xue C; Hakimelahi S; Moosavi-Movahedi AA; Saboury AA; Khalafi-Nezhad A; Soltani-Rad MN; Osyetrov V; Wang K; Liao JH; Luo FT
Bioorg Med Chem; 2002 Nov; 10(11):3489-98. PubMed ID: 12213463
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
9. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem.
Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484
[TBL] [Abstract][Full Text] [Related]
10. THF carbapenems. Wyeth Ayerst.
Jiraskova N
Curr Opin Investig Drugs; 2001 Aug; 2(8):1035-8. PubMed ID: 11892910
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
13. Carbapenems in the USA: focus on doripenem.
Lister PD
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H
J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646
[TBL] [Abstract][Full Text] [Related]
15. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains].
Nowak P; Targosz A; Budak A; Oleksiak D; Geza G; Skałkowska M
Med Dosw Mikrobiol; 2006; 58(3):231-7. PubMed ID: 17340998
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
Fritsche TR; Stilwell MG; Jones RN
Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
[TBL] [Abstract][Full Text] [Related]
18. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
[TBL] [Abstract][Full Text] [Related]
19. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus.
Huber J; Donald RG; Lee SH; Jarantow LW; Salvatore MJ; Meng X; Painter R; Onishi RH; Occi J; Dorso K; Young K; Park YW; Skwish S; Szymonifka MJ; Waddell TS; Miesel L; Phillips JW; Roemer T
Chem Biol; 2009 Aug; 16(8):837-48. PubMed ID: 19716474
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases.
Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN
Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
